Research Paper Volume 16, Issue 3 pp 2320—2339
Comprehensive analysis of ALG3 in pan-cancer and validation of ALG3 as an onco-immunological biomarker in breast cancer
Figure 6. ScRNA analysis of ALG3 expression on different cells of breast cancer. (A) Functional pathways involved in ALG3, revealed by CANCERSEA website. (B) The analysis of the expression of PUDP on the cell in the tumor microenvironment. (C) Log-normalized expression of markers for ALG3 in breast cancer. (D, E) ALG3 expression level in different clinical subtype was demonstrated.